Let’s confront Idiopathic Pulmonary Fibrosis together
Will you join us in our search for new ways to treat idiopathic pulmonary fibrosis (IPF)? We’re looking for patients with the condition to join the RIFF clinical research study.
Read on and find out if you can help Can I take part?What is pulmonary fibrosis?
‘Pulmonary’ means ‘lung’ and ‘fibrosis’ means scar tissue. And that’s precisely what pulmonary fibrosis is – a scarring of the lungs that makes breathing difficult. The specific type of pulmonary fibrosis we are studying is ‘idiopathic’, meaning there is no known cause of the disease. Nobody knows exactly why one person develops the condition and another doesn’t. However, certain activities (such as smoking) increase your risk of developing IPF.
Symptoms
-
Dry, hacking cough
-
Rapid shallow breathing
-
Shortness of breath
-
Unintended weight loss
-
A general feeling of being unwell
-
Fatigue (tiredness)
-
Aching muscles and joints
-
Clubbing of the fingers and toes
Some activities increase your risk of developing IPF, these include:
-
Certain occupations such as mining -
Smoking -
Some cancer medications
Unfortunately, there is no cure for IPF and current treatments just aim to ease symptoms. Thus many patients are choosing to join clinical studies to help the medical community find new treatment options – studies like RIFF.
Can I take part?About the RIFF Study
The RIFF clinical research study is looking at the effect of an investigational medication in people with IPF. 250 patients are expected to take part at about 100 study sites around the world.
Can I take part?
Blood tests
Vital signs examinations
Urine tests
Lung function tests (more details to follow)
Electrocardiograms
6-minute walk tests
Physical assessments
Quality of life questionnairesFind my local site
-
A
Study site name
55 - 57 High Street Windsor, SL4 1LP
Select this site -
B
Study site name
55 - 57 High Street Windsor, SL4 1LP
Select this site -
C
Study site name
55 - 57 High Street Windsor, SL4 1LP
Select this site
About clinical studies
Every year, thousands of people around the world take part in clinical research studies. Without clinical studies, new drugs can’t be developed and go to market.
-
4,000
Studies looking at new investigational treatments*
-
120
New drugs approved for patient use*
* as of September 2014 www.centerwatch.com
Doctors and nurses carry out these carefully designed scientific tests to help us answer questions about investigational medications such as:
- How it acts in the body
- How it affects certain diseases or conditions
- Whether or not it is safe for wider use
Independent institutional review boards and ethics committees look after the best interests of these participants by:
- Protecting their rights
- Ensuring they aren’t exposed to unnecessary risks
Can I take part?
To take part in a clinical research study, you must meet a set of requirements specific to that study. This helps make sure that the study is the right choice for you. To see if you qualify for the RIFF study, please take 5 minutes to fill out the following form (this information will be kept confidential). You can also fill out the form on behalf of a loved one.
-
Are you aged at least 40 years old?
Yes No -
Were you diagnosed with IPF within the last 5 years?
Yes No Unsure -
Do you have any other lung disease (e.g., asthma or COPD)?
Yes No Unsure -
Can you walk at least 100 meters in 6 minutes (about the length of a football field)?
Yes No Unsure -
Have you been hospitalized due to IPF within the last 4 weeks?
Yes No Unsure
Resources
Please download this patient leaflet for more information about the RIFF study.
For more information about IPF in general, please see the following websites:
Can I take part?Find out more
Thank you for your interest in the RIFF clinical research study. To request more information, please complete the following form
My details
Thank you
Someone from the site will contact you in the coming days. We appreciate your interest and look forward to discussing the study with you further.
Refer a patient
Please enter their details below and select their local site. The site will then contact them in the coming days with more information about the study. Please be reassured that this information will be kept confidential.
Patients details
Thank you for referring
Someone from the site will contact the patient in the coming days. We appreciate their interest and look forward to discussing the study with them further.